ArticleMedicine2020

Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination: Real-world experience of a retrospective study.

Juan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.